Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection
Kylie M. Konrath, Kevin Liaw, Yuanhan Wu, et al.
Cell Reports (2022) Vol. 38, Iss. 5, pp. 110318-110318
Open Access | Times Cited: 19

Showing 19 citing articles:

Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses
Wanting He, Rami Musharrafieh, Ge Song, et al.
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 960-970
Open Access | Times Cited: 56
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
Bin Ju, Qi Zhang, Ziyi Wang, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 690-699
Open Access | Times Cited: 31
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 10
Vaccine adjuvants for infectious disease in the clinic
Morgan Goetz, Naaz Thotathil, Zongmin Zhao, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 4
Open Access | Times Cited: 8
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques
Wanting He, Meng Yuan, Sean Callaghan, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 657
Open Access | Times Cited: 30
Advances of microfluidic lung chips for assessing atmospheric pollutants exposure
Hui Wang, Fangchao Yin, Zhongyu Li, et al.
Environment International (2023) Vol. 172, pp. 107801-107801
Open Access | Times Cited: 19
Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains
Jing Yang Wang, Alena Khmelinskaia, William Sheffler, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 11
Open Access | Times Cited: 10
Nanoparticles for Coronavirus Control
Maryam Kianpour, Mohsen Akbarian, Vladimir N. Uversky
Nanomaterials (2022) Vol. 12, Iss. 9, pp. 1602-1602
Open Access | Times Cited: 14
Current clinical status of new COVID-19 vaccines and immunotherapy
Diksha Nagpal, Shakti Nagpal, Deepak Kaushik, et al.
Environmental Science and Pollution Research (2022)
Open Access | Times Cited: 14
Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus
Zhannan Wang, Tongyu Zhang, Futing Jia, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 5
Strategies for developing self-assembled nanoparticle vaccines against SARS-CoV-2 infection
Kaiwen Yang, Youqin Zeng, Xinyu Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Gene‐encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity
Nicholas J. Tursi, Ziyang Xu, Daniel W. Kulp, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 4
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models
Viviane M. Andrade, Igor Maricic, Richa Kalia, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 4
How Is Mass Spectrometry Tackling the COVID-19 Pandemic?
Alfredo J. Ibáñez
Frontiers in Analytical Science (2022) Vol. 2
Open Access | Times Cited: 6
Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like viruses
Wanting He, Rami Musharrafieh, Ge Song, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains
Jing Yang Wang, Alena Khmelinskaia, William Sheffler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein
María Celeste Rodríguez, Natalia Ceaglio, Agustina Gugliotta, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 23, pp. 7933-7948
Open Access | Times Cited: 4
Computationally designed mRNA-launched protein nanoparticle vaccines
G. Hendricks, Lilit Grigoryan, Mary Jane Navarro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pandemic’s silver lining
Fortunato Ferrara, Sara D’Angelo, M. Frank Erasmus, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top